title: Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.
authors.forename: H J
authors.initials: HJ
authors.lastname: Lee
authors.forename: A
authors.initials: A
authors.lastname: Gulbis
authors.forename: L
authors.initials: L
authors.lastname: De Padua Silva
authors.forename: C
authors.initials: C
authors.lastname: Hosing
authors.forename: I
authors.initials: I
authors.lastname: Khouri
authors.forename: M
authors.initials: M
authors.lastname: de Lima
authors.forename: R E
authors.initials: RE
authors.lastname: Champlin
authors.forename: S O
authors.initials: SO
authors.lastname: Ciurea
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology; D000368:Aged; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000276:immunology*; D001803:Blood Transfusion; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015477:Leukemia, Myelomonocytic, Chronic / Q000628:therapy; D000069283:Rituximab; D013577:Syndrome; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab